Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases
- PMID: 11527792
- PMCID: PMC96160
- DOI: 10.1128/CDLI.8.5.859-863.2001
Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases
References
-
- Amer J, Ott E, Ibbott F A, O'Brien D, Kempe C H. The effect of monthly gamma-globulin administration on morbidity and mortality from infection in premature infants during the first year of life. Pediatrics. 1963;32:4–9. - PubMed
-
- American Academy of Pediatrics. 2000 Red Book: report of the Committee on Infectious Diseases. 25th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 2000. pp. 42–44.
-
- American Academy of Pediatrics. 2000 Red Book: report of the Committee on Infectious Diseases. 25th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 2000.
-
- Baba T W, Liska V, Hofmann-Lehmann R, Vlasak J, Xu W, Oyehunie S, Cavancini L A, Posner M R, Katinger H, Stiegler G, Bernacky B J, Rizvi T A, Schmidt R, Hill L R, Keeling M E, Lu Y, Wright J E, Chou T C, Ruprecht R M. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med. 2000;6:200–206. - PubMed
-
- Baker C J, Melish M E, Hall R T, Casto D T, Vasan U, Givner L B the Multicenter Group for the Study of Immune Globulin in Neonates. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. N Engl J Med. 1992;327:213–219. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
